Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K) Under 10b5-1 Plan

The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) common stock at a price of $82.3071 per share on March 21, 2025, according to a Form 4 filing.

Summary

• On March 21, 2025, the W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) common stock.
• The sale was executed at a price of $82.3071 per share.
• Following the transaction, the Trust beneficially owns 47,503,697 shares of Kellanova.
• The sales were made pursuant to trading instructions given on May 7, 2024, intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934.
• LaJune Montgomery Tabron, Steve Cahillane, Richard M. Tsoumas, and The Northern Trust Company are Trustees of the W.K. Kellogg Foundation Trust, with the W.K. Kellogg Foundation as the sole beneficiary.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reports a transaction without expressing any positive or negative views about the company's performance or future prospects. The sale is conducted under a pre-arranged plan, which reduces the likelihood of it being driven by negative sentiment.

Industry Context

Sales by major shareholders, especially those related to foundations, are often scrutinized by the market for potential insights into the company's prospects or the foundation's strategic asset allocation decisions. The use of a 10b5-1 plan suggests the sale was pre-planned and intended to avoid concerns about insider trading.

Stakeholder Impact

• The sale of shares by a major shareholder like the W.K. Kellogg Foundation Trust could have a minor impact on shareholder confidence, although the pre-planned nature of the sale mitigates this.
• The proceeds from the sale will likely benefit the W.K. Kellogg Foundation's charitable activities.

Key Dates

Keywords

Kellanova, WK Kellogg Foundation Trust, Form 4, Share Sale, Rule 10b5-1, Beneficial Ownership, Securities Exchange Act